{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:55:20Z","timestamp":1791179720386,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.07.095","type":"journal-article","created":{"date-parts":[[2009,10,17]],"date-time":"2009-10-17T08:27:11Z","timestamp":1255768031000},"page":"D80-D85","source":"Crossref","is-referenced-by-count":99,"special_numbering":"S4","title":["Vaccines for Venezuelan equine encephalitis"],"prefix":"10.1016","volume":"27","author":[{"given":"Slobodan","family":"Paessler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.07.095_bib1","series-title":"The togaviruses and flaviviruses","first-page":"35","article-title":"Structure and replication of the alphavirus genome","author":"Strauss","year":"1986"},{"key":"10.1016\/j.vaccine.2009.07.095_bib2","series-title":"Virus Taxonomy Sixth Report of the International Committee on Taxonomy of Viruses","first-page":"428","article-title":"Togaviridae","author":"Strauss","year":"1995"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.095_bib3","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/MMBR.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol Rev"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.095_bib4","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1073\/pnas.78.4.2062","article-title":"Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins","volume":"78","author":"Rice","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.07.095_bib5","series-title":"Encyclopedia of virology","first-page":"76","article-title":"Togaviruses causing encephalitis (Togaviridae)","author":"Paessler","year":"2008"},{"key":"10.1016\/j.vaccine.2009.07.095_bib6","first-page":"99","article-title":"A molecular genetic approach to the study of Venezuelan equine encephalitis virus pathogenesis","volume":"9","author":"Davis","year":"1994","journal-title":"Arch Virol Suppl"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.095_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4049\/jimmunol.96.1.49","article-title":"Pathogenesis of Venezuelan equine encephalomyelitis virus. II. Infection in young adult mice","volume":"96","author":"Kundin","year":"1966","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.07.095_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/030098589102800509","article-title":"Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters","volume":"28","author":"Jackson","year":"1991","journal-title":"Vet Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.095_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/viro.1995.1458","article-title":"Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1","volume":"212","author":"Davis","year":"1995","journal-title":"Virology"},{"issue":"109","key":"10.1016\/j.vaccine.2009.07.095_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0165-5728(00)00290-3","article-title":"Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice","author":"Schoneboom","year":"2000","journal-title":"J Neuroimmunol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.095_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/13550289909029475","article-title":"Astrocytes as targets for Venezuelan equine encephalitis virus infection","volume":"5","author":"Schoneboom","year":"1999","journal-title":"J Neurovirol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.095_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/viro.1997.8617","article-title":"Kinetics of cytokine expression and regulation of host protection following infection with molecularly cloned Venezuelan equine encephalitis virus","volume":"233","author":"Grieder","year":"1997","journal-title":"Virology"},{"issue":"128","key":"10.1016\/j.vaccine.2009.07.095_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/path.1711280206","article-title":"Central nervous system alterations as sequelae of Venezuelan equine encephalitis virus infection in rat","volume":"128","author":"Garcia-Tamayo","year":"1979","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.095_bib14","first-page":"425","article-title":"Venezuelan equine encephalomyelitis in an adult animal host. An electron microscopic study","volume":"73","author":"Gorelkin","year":"1973","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.095_bib15","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1006\/viro.1995.1022","article-title":"Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins","volume":"206","author":"Grieder","year":"1995","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.vaccine.2009.07.095_bib16","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/BF01323243","article-title":"Spread of Venezuelan equine encephalitis virus in mice olfactory tract","volume":"140","author":"Ryzhikov","year":"1995","journal-title":"Arch Virol"},{"issue":"February (13)","key":"10.1016\/j.vaccine.2009.07.095_bib17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.vaccine.2004.06.056","article-title":"Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus","volume":"23","author":"Phillpotts","year":"2005","journal-title":"Vaccine"},{"issue":"February (11\u201312)","key":"10.1016\/j.vaccine.2009.07.095_bib18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0264-410X(01)00505-9","article-title":"Monoclonal antibody protects mice against infection and disease when given either before or up to 24h after airborne challenge with virulent Venezuelan equine encephalitis virus","volume":"20","author":"Phillpotts","year":"2002","journal-title":"Vaccine"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2009.07.095_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.virol.2007.05.041","article-title":"Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection","volume":"367","author":"Paessler","year":"2007","journal-title":"Virology"},{"issue":"June (30)","key":"10.1016\/j.vaccine.2009.07.095_bib20","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2009.04.015","article-title":"CD4+ T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus","volume":"27","author":"Yun","year":"2009","journal-title":"Vaccine"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2009.07.095_bib21","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/JVI.80.6.2784-2796.2006","article-title":"Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN\/VEE viruses","volume":"80","author":"Paessler","year":"2006","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.095_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/vim.1998.11.109","article-title":"Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus","volume":"11","author":"Bennett","year":"1998","journal-title":"Viral Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.07.095_bib23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0168-1702(02)00275-7","article-title":"Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice","volume":"91","author":"Jones","year":"2003","journal-title":"Virus Res"},{"issue":"13","key":"10.1016\/j.vaccine.2009.07.095_bib24","doi-asserted-by":"crossref","first-page":"6156","DOI":"10.1128\/JVI.74.13.6156-6161.2000","article-title":"Differences between C57BL\/6 and BALB\/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus","volume":"74","author":"Thach","year":"2000","journal-title":"J Virol"},{"issue":"June (1\u20132)","key":"10.1016\/j.vaccine.2009.07.095_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0165-5728(02)00108-X","article-title":"Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis","volume":"127","author":"Rowell","year":"2002","journal-title":"J Neuroimmunol"},{"issue":"December","key":"10.1016\/j.vaccine.2009.07.095_bib26","first-page":"209","article-title":"FOXP3: of mice and men","volume":"24","author":"Ziegler","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"February (5609)","key":"10.1016\/j.vaccine.2009.07.095_bib27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2009.07.095_bib28","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/sj.gt.3302567","article-title":"In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity","volume":"12","author":"Loser","year":"2005","journal-title":"Gene Ther"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2009.07.095_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.icb.7100012","article-title":"Immunopathology of flavivirus infections","volume":"85","author":"King","year":"2007","journal-title":"Immunol Cell Biol"},{"issue":"18","key":"10.1016\/j.vaccine.2009.07.095_bib30","first-page":"161","article-title":"Neurovirulence and host factors in flavivirus encephalitis\u2014evidence from clinical epidemiology","author":"Solomon","year":"2004","journal-title":"Arch Virol Suppl"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2009.07.095_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0952-7915(96)80033-1","article-title":"Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses","volume":"8","author":"Kagi","year":"1996","journal-title":"Curr Opin Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.07.095_bib32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nri1105","article-title":"Immune responses to RNA-virus infections of the CNS","volume":"3","author":"Griffin","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2009.07.095_bib33","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/eji.200324034","article-title":"Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution","volume":"33","author":"Ma","year":"2003","journal-title":"Eur J Immunol"},{"issue":"January (1 Suppl.)","key":"10.1016\/j.vaccine.2009.07.095_bib34","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.TP.0000106473.46037.83","article-title":"The cytotoxic potential of regulatory T cells: what has been learned from gene knockout model systems?","volume":"77","author":"Marks","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.vaccine.2009.07.095_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0074-7696(08)62169-5","article-title":"Dual mechanisms of apoptosis induction by cytotoxic lymphocytes","volume":"182","author":"Trapani","year":"1998","journal-title":"Int Rev Cytol"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2009.07.095_bib36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0952-7915(98)80227-6","article-title":"How do cytotoxic lymphocytes kill their targets?","volume":"10","author":"Shresta","year":"1998","journal-title":"Curr Opin Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.07.095_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF02786434","article-title":"Fas- and perforin-independent mechanism of cytotoxic T lymphocyte","volume":"17","author":"Kajino","year":"1998","journal-title":"Immunol Res"},{"issue":"October (4 Pt 2)","key":"10.1016\/j.vaccine.2009.07.095_bib38","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1164\/ajrccm.162.supplement_3.15tac4","article-title":"Gammadelta cells and the regulation of mucosal immune responses","volume":"162","author":"Hayday","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2009.07.095_bib39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1146\/annurev.immunol.18.1.975","article-title":"[gamma][delta] cells: a right time and a right place for a conserved third way of protection","volume":"18","author":"Hayday","year":"2000","journal-title":"Annu Rev Immunol"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2009.07.095_bib40","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.171.5.2524","article-title":"IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection","volume":"171","author":"Wang","year":"2003","journal-title":"J Immunol"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2009.07.095_bib41","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.4049\/jimmunol.169.6.3163","article-title":"Gamma\/delta T cell-deficient mice exhibit reduced disease severity and decreased inflammatory response in the brain in murine neurocysticercosis","volume":"169","author":"Cardona","year":"2002","journal-title":"J Immunol"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2009.07.095_bib42","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0002-9440(10)64402-1","article-title":"Virus-induced demyelination in nude mice is mediated by gamma delta T cells","volume":"161","author":"Dandekar","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2009.07.095_bib43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"Use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.07.095_bib44","first-page":"209","article-title":"Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells","volume":"73","author":"Berge","year":"1961","journal-title":"Am J Hyg"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.07.095_bib45","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1128\/IAI.5.5.750-756.1972","article-title":"Experimental infection of horses with an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83)","volume":"5","author":"Walton","year":"1972","journal-title":"Infect Immun"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2009.07.095_bib46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.07.095_bib47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/JCM.19.3.429-431.1984","article-title":"Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters","volume":"19","author":"Jahrling","year":"1984","journal-title":"J Clin Microbiol"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2009.07.095_bib48","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0264-410X(97)00192-8","article-title":"Use of telemetry to assess vaccine-induced protection against parenteral and aerosol infections of Venezuelan equine encephalitis virus in non-human primates","volume":"16","author":"Pratt","year":"1998","journal-title":"Vaccine"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2009.07.095_bib49","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/JVI.67.3.1269-1277.1993","article-title":"Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5\u2032-noncoding region and the E2 envelope glycoprotein","volume":"67","author":"Kinney","year":"1993","journal-title":"J Virol"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2009.07.095_bib50","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2009.07.095_bib51","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/S0264-410X(00)00042-6","article-title":"Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate","volume":"18","author":"Hart","year":"2000","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.07.095_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4269\/ajtmh.2001.64.49","article-title":"Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice","volume":"64","author":"Ludwig","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.095_bib53","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4269\/ajtmh.1999.60.1041","article-title":"Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates","volume":"60","author":"Turell","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"June (20)","key":"10.1016\/j.vaccine.2009.07.095_bib54","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.vaccine.2003.09.041","article-title":"Environmental hazard assessment of Venezuelan equine encephalitis virus vaccine candidate strain V3526","volume":"22","author":"Rao","year":"2004","journal-title":"Vaccine"},{"issue":"May (24)","key":"10.1016\/j.vaccine.2009.07.095_bib55","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.vaccine.2004.12.023","article-title":"Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus","volume":"23","author":"Reed","year":"2005","journal-title":"Vaccine"},{"issue":"June (27\u201328)","key":"10.1016\/j.vaccine.2009.07.095_bib56","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1016\/j.vaccine.2008.04.044","article-title":"Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates","volume":"26","author":"Fine","year":"2008","journal-title":"Vaccine"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2009.07.095_bib57","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/oxfordjournals.aje.a121416","article-title":"Isolation of the vaccine strain of Venezuelan equine encephalomyelitis virus from mosquitoes in Louisiana","volume":"95","author":"Pedersen","year":"1972","journal-title":"Am J Epidemiol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2009.07.095_bib58","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2008.04.020","article-title":"IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells","volume":"377","author":"Volkova","year":"2008","journal-title":"Virology"},{"issue":"2292","key":"10.1016\/j.vaccine.2009.07.095_bib59","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.88.2292.530","article-title":"Venezuelan equine encephalomyelitis","volume":"88","author":"Beck","year":"1938","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.07.095_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1126\/science.90.2323.20","article-title":"The causitive agent of infectious equine encephalomyelitis in Venezuela","volume":"90","author":"Kubes","year":"1939","journal-title":"Science"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2009.07.095_bib61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.63.3.313","article-title":"Immunization of laboratory workers with purified Venezuelan equine encephalomyelitis vaccine","volume":"63","author":"Randall","year":"1949","journal-title":"J Immunol"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2009.07.095_bib62","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1099\/0022-1317-73-12-3301","article-title":"Molecular evidence for the origin of the widespread Venezuelan equine encephalitis epizootic of 1969 to 1972","volume":"73","author":"Kinney","year":"1992","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.07.095_bib63","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4269\/ajtmh.1999.60.441","article-title":"Genetic evidence for the origins of Venezuelan equine encephalitis virus subtype IAB outbreaks","volume":"60","author":"Weaver","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"17","key":"10.1016\/j.vaccine.2009.07.095_bib64","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.1954.03690350015005","article-title":"Venezuelan equine encephalomyelitis due to vaccination in man","volume":"155","author":"Sutton","year":"1954","journal-title":"J Am Med Assoc"},{"issue":"October (43)","key":"10.1016\/j.vaccine.2009.07.095_bib65","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1016\/j.vaccine.2007.07.061","article-title":"Chimeric Sindbis\/eastern equine encephalitis vaccine candidates are highly attenuated and immunogenic in mice","volume":"25","author":"Wang","year":"2007","journal-title":"Vaccine"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2009.07.095_bib66","doi-asserted-by":"crossref","first-page":"9278","DOI":"10.1128\/JVI.77.17.9278-9286.2003","article-title":"Recombinant sindbis\/Venezuelan equine encephalitis virus is highly attenuated and immunogenic","volume":"77","author":"Paessler","year":"2003","journal-title":"J Virol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.07.095_bib67","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4269\/ajtmh.2007.76.774","article-title":"Recombinant alphaviruses are safe and useful serological diagnostic tools","volume":"76","author":"Ni","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.095_bib68","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/JVI.71.4.2819-2829.1997","article-title":"Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA","volume":"71","author":"Frolov","year":"1997","journal-title":"J Virol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2009.07.095_bib69","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nbt1291-1356","article-title":"A new generation of animal cell expression vectors based on the Semliki Forest virus replicon","volume":"9","author":"Liljestrom","year":"1991","journal-title":"Biotechnology (NY)"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.095_bib70","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2009.07.095_bib71","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1073\/pnas.96.8.4598","article-title":"Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors","volume":"96","author":"Polo","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (16)","key":"10.1016\/j.vaccine.2009.07.095_bib72","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/0264-410X(94)90074-4","article-title":"Self-replicating Semliki Forest virus RNA as recombinant vaccine","volume":"12","author":"Zhou","year":"1994","journal-title":"Vaccine"},{"issue":"4\u20135","key":"10.1016\/j.vaccine.2009.07.095_bib73","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/15216540212657","article-title":"Alphavirus replicon particles as candidate HIV vaccines","volume":"53","author":"Davis","year":"2002","journal-title":"IUBMB Life"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2009.07.095_bib74","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1073\/pnas.0600287103","article-title":"Mucosal and systemic adjuvant activity of alphavirus replicon particles","volume":"103","author":"Thompson","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"June (31)","key":"10.1016\/j.vaccine.2009.07.095_bib75","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.vaccine.2009.04.049","article-title":"Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine","volume":"27","author":"Dupuy","year":"2009","journal-title":"Vaccine"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2009.07.095_bib76","first-page":"233","article-title":"Vaccinia virus recombinants encoding the truncated structural gene region of Venezuelan equine encephalitis virus (VEEV) give solid protection against peripheral challenge but only partial protection against airborne challenge with virulent VEEV","volume":"44","author":"Phillpotts","year":"2000","journal-title":"Acta Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09011323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09011323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T06:22:17Z","timestamp":1685168537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09011323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":76,"alternative-id":["S0264410X09011323"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.095","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}